STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Ginkgo Bioworks (NYSE: DNA) has scheduled its third quarter 2024 business performance presentation and Q&A session for Tuesday, November 12, 2024, at 5:30 p.m. ET, after market close. The presentation will cover results for the quarter ended September 30, 2024. Investors can access the webcast through Ginkgo's investor relations website, where a replay will also be available. Questions can be submitted beforehand via X (using #GinkgoResults) or email.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+4.72% News Effect

On the day this news was published, DNA gained 4.72%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Presentation and Q&A session scheduled for post-market on Tuesday, November 12, 2024

BOSTON, Nov. 5, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing business performance for the third quarter ended September 30, 2024, on Tuesday, November 12, 2024, beginning at 5:30 p.m. ET.

The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available.

To ask a question ahead of the presentation, please submit them to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.

About Ginkgo Bioworks

Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats.  For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks) or LinkedIn.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:

investors@ginkgobioworks.com     

MEDIA CONTACT:

press@ginkgobioworks.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-third-quarter-2024-results-presentation-302295611.html

SOURCE Ginkgo Bioworks

FAQ

When will Ginkgo Bioworks (DNA) release Q3 2024 earnings?

Ginkgo Bioworks will release its Q3 2024 earnings on Tuesday, November 12, 2024, at 5:30 p.m. ET, after market close.

How can I access Ginkgo Bioworks (DNA) Q3 2024 earnings call?

The earnings presentation can be accessed through Ginkgo's investor relations website at investors.ginkgobioworks.com, where a replay will also be available.

How can investors submit questions for Ginkgo Bioworks (DNA) Q3 2024 earnings call?

Investors can submit questions either through X (using #GinkgoResults) or by sending an email to investors@ginkgobioworks.com.
Ginkgo Bioworks Holdings Inc

NYSE:DNA

DNA Rankings

DNA Latest News

DNA Latest SEC Filings

DNA Stock Data

599.84M
58.30M
6.73%
79.11%
11.33%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
BOSTON